SOURCE: Transbiotec, Inc.

April 05, 2012 09:00 ET

Transbiotec, Inc. Announces New Patent Filing

SEAL BEACH, CA--(Marketwire - Apr 5, 2012) - Transbiotec, Inc. (OTCBB: IMLE) announces that it has filed another patent application with the USPTO, continuing to expand the company's Intellectual Property Portfolio around its SOBR product. SOBR's transdermal alcohol sensing technology determines how much alcohol a person has consumed by a touch of a finger on the sensor. The patent filing incorporates the latest product improvements. These include advanced microprocessor control, expanded interfaces to standard computer bus systems and advanced data handling to provide greater measurement repeatability.

Transbiotec, Inc. based in Seal Beach, CA, trades under the symbol IMLE on OTC BB. For more information contact the Company at info@transbiotec.com, or by calling 562-280-0483.

Contact Information